Ad is loading...
MYNDF
Price
$0.01
Change
-$0.00 (-0.00%)
Updated
Nov 12 closing price
NERV
Price
$2.20
Change
-$0.12 (-5.17%)
Updated
Nov 15 closing price
121 days until earnings call
Ad is loading...

MYNDF vs NERV

Header iconMYNDF vs NERV Comparison
Open Charts MYNDF vs NERVBanner chart's image
MYND Life Sciences
Price$0.01
Change-$0.00 (-0.00%)
Volume$300
CapitalizationN/A
Minerva Neurosciences
Price$2.20
Change-$0.12 (-5.17%)
Volume$34.58K
CapitalizationN/A
MYNDF vs NERV Comparison Chart
Loading...
NERV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
MYNDF vs. NERV commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MYNDF is a Buy and NERV is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (MYNDF: $0.01 vs. NERV: $2.20)
Brand notoriety: MYNDF and NERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MYNDF: 144% vs. NERV: 192%
Market capitalization -- MYNDF: $1.7M vs. NERV: $15.39M
MYNDF [@Biotechnology] is valued at $1.7M. NERV’s [@Biotechnology] market capitalization is $15.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MYNDF’s FA Score shows that 1 FA rating(s) are green whileNERV’s FA Score has 0 green FA rating(s).

  • MYNDF’s FA Score: 1 green, 4 red.
  • NERV’s FA Score: 0 green, 5 red.
According to our system of comparison, MYNDF is a better buy in the long-term than NERV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NERV’s TA Score shows that 3 TA indicator(s) are bullish.

  • NERV’s TA Score: 3 bullish, 4 bearish.

Price Growth

MYNDF (@Biotechnology) experienced а 0.00% price change this week, while NERV (@Biotechnology) price change was -6.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

NERV is expected to report earnings on Mar 18, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NERV($15.4M) has a higher market cap than MYNDF($1.7M). MYNDF YTD gains are higher at: -59.936 vs. NERV (-64.226). MYNDF has higher annual earnings (EBITDA): -273.7K vs. NERV (-24.78M). NERV has more cash in the bank: 30.9M vs. MYNDF (1.81K). NERV has less debt than MYNDF: NERV (0) vs MYNDF (3M). MYNDF has higher revenues than NERV: MYNDF (1) vs NERV (0).
MYNDFNERVMYNDF / NERV
Capitalization1.7M15.4M11%
EBITDA-273.7K-24.78M1%
Gain YTD-59.936-64.22693%
P/E RatioN/AN/A-
Revenue10-
Total Cash1.81K30.9M0%
Total Debt3M0-
FUNDAMENTALS RATINGS
NERV: Fundamental Ratings
NERV
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NERV
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Declines
ODDS (%)
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
79%
Aroon
ODDS (%)
Bearish Trend 3 days ago
81%
View a ticker or compare two or three
Ad is loading...
NERV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HEIIX14.89-0.05
-0.33%
Hennessy Equity and Income Institutional
COSDX10.37-0.04
-0.38%
Columbia Overseas Core Advisor
IHGIX37.42-0.19
-0.51%
Hartford Dividend and Growth A
ABYSX25.20-0.20
-0.79%
AB Discovery Value Advisor
SPFIX83.29-1.11
-1.32%
Shelton S&P 500 Index Investor

MYNDF and

Correlation & Price change

A.I.dvisor tells us that MYNDF and NERV have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MYNDF and NERV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYNDF
1D Price
Change %
MYNDF100%
N/A
NERV - MYNDF
29%
Poorly correlated
-5.17%
ICCC - MYNDF
23%
Poorly correlated
+0.28%
CSBR - MYNDF
20%
Poorly correlated
+0.90%
AEON - MYNDF
7%
Poorly correlated
+0.87%
INKT - MYNDF
4%
Poorly correlated
+0.53%
More

NERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, NERV has been loosely correlated with SYRE. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if NERV jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NERV
1D Price
Change %
NERV100%
-5.17%
SYRE - NERV
35%
Loosely correlated
-6.62%
MYNDF - NERV
29%
Poorly correlated
N/A
MIST - NERV
27%
Poorly correlated
-6.08%
SWTX - NERV
26%
Poorly correlated
-0.27%
ATOS - NERV
24%
Poorly correlated
-6.57%
More